In contrast, global AR knockout mice (ARKO) treated with testosterone exhibit normal estrous cycles and corpus luteum formation, suggesting that the action of testosterone may primarily occur in non-ovarian tissues, which is the key site for the androgenic action that produces the PCOS phenotype (Caldwell et al., 2017). This evidence concerns the gene AR and polycystic ovary syndrome.